Reviewer Board

Members of the reviewer board are selected from all Onco reviewers for regularly providing timely high quality reports on submitted manuscripts. Responsibilities of reviewers are available here.


Division of Gastroenterology and the Inflammatory Bowel Diseases Center, Washington University School of Medicine, St. Louis, MO 63110, USA
Interests: gastrointestinal cancer; colorectal cancer; epigenetics
Section of Molecular Pathology, Department of Emergency and Organ Transplantation (DETO), University of Bari "Aldo Moro", P.zza Giulio Cesare 11
Interests: melanoma; dermatopahology; skin; soft tissue; sarcoma; malignancy; cancer; papillary

Thoraxklinik and National Center for Tumor Diseases (NCT) at Heidelberg University Hospital, Department of Thoracic Oncology, Roentgensstr. 1, 69126 Heidelberg, Germany
Interests: molecular risk stratification; non-invasive monitoring; strategies to overcome TKI and immunotherapy resistance in thoracic malignancies
Department of Pathology, Saga University Hospital, Saga 849-8501, Japan
Interests: surgical pathology of the gastrointestinal tract; liver; biliary tract and pancreas; cancer immunology; general pathology and cytology

Fondazione Policlinico Universitario "A. Gemelli" IRCCS, UOC Radioterapia Oncologica, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, 00128, Rome, Italy.
Interests: brachytherapy; gynecological cancer; head and neck cancer; breast cancer; skin cancer

Department of Genetics, Physical Anthropology and Animal Physiology, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain
Interests: lymphoma; leukemia; childhood; pharmacogenomics; susceptibility; prognosis

Unit of Radiation Medicine, National Public Health Centre, 1221 Budapest, Hungary
Interests: radiation biology; immunology; oncology; extracellular vesicles

Department of Biochemistry and Molecular Biology, Mayo Clinic Florida, Jacksonville, FL 32224, USA
Interests: cancer biology; pancreatic cancer; breast cancer; renal cell carcinoma; GBM; targeted drug delivery vehicles; nanoparticles; liposomes; drug resistance

University of Nebraska Medical Center, Omaha, NE, USA
Interests: cancer therapy; cell signaling; anti-cancer agents; proteomics; proteolysis targeting chimeras (PROTACs); drug discovery

Thoracic Surgery Department, Medical University of Gdansk, Smoluchowskiego, 1780-214 Gdansk, Poland
Interests: thoracic surgery; lung cancer; mesothelioma; thymoma; tracheal cancer; neoadjuvant; vats; immunotherapy; pleura; mediastinum; metastases

Faculty of Science and Engineering, Pharmaceutical Analysis — Groningen Research Institute of Pharmacy, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands
Interests: tumor microenvironment; therapy resistance; 3D models; cancer-on-chip technology; biomaterials

Section of Benign Hematology, Department of Pulmonary Medicine, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA
Interests: hemostasis and thrombosis; general hematology

Radiation Oncology Section, Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy
Interests: breast cancer; prostate cancer; CNS cancers; radiotherapy; radiobiology

1. Harper Cancer Research Institute, South Bend, IN 46617, USA
2. Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, South Bend, IN 46617, USA
3. Department of Biological Sciences, University of Notre Dame, Notre Dame, IN 46556, USA
Interests: chemoresistance in breast cancer; targeted therapy; epithelial polarity; APC tumor suppressor; mouse models

Oslo University Hospital, Oslo, Norway
Interests: breast cancer; surgery; oncology
Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
Interests: tumor signaling and microenvironment; oncogene; cellular stress; ER stress; kinases; DNA damage response; immunotherapy; targeted therapy

Division of Oncology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA
Interests: cancer cell metabolism; head and neck squamous cell carcinoma; radiotherapy and drug combinatorial strategies development; radiobiology; proton therapy
Wake Forest School of Medicine, 300 Medical Centre Blvd, Winston Salem, NC, USA
Interests: cancer cell metabolism; signaling and redox homeostasis; free radical biology; chemoradiation therapy; energy metabolism; inflammation and antioxidant; lipid peroxidation; protein thiol modification
Eppley Institute, University of Nebraska Medical Center, Omaha, NE 68198, USA
Interests: anti-cancer drug discovery; proteolysis targeting chimera (PROTACs); kinase inhibition
Max Planck Institute for Heart and Lung Research, Member of the German Center for Lung Research (DZL), Member of the Cardio-Pulmonary Institute (CPI), 61231 Bad Nauheim, Germany
Interests: lung cancer; glioma; tumor microenvironment; targeted therapy; microRNA

Faculty of Medicine, Department of Neurosurgery, University of Tsukuba, Ibaraki 305-8577, Japan
Interests: BNCT; glioma; glioblastoma; irradiation experiments; tumor cells; boron neutron capture therapy; preclinical study
Back to TopTop